Alpha-Synuclein Inhibitors Clinical Trial Pipeline As Novel And Extensive 22+ Therapies Likely To Enter In The Domain | Delveinsight
Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...
The Schall Law Firm Invites Shareholders With Losses In Cerevel Therapeutics Holdings, Inc. To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / February 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
TMCnet2d
CERE Investors Have Opportunity to Join Cerevel Therapeutics Holdings, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or "the Company") ...
BioSpace5d
Bain Bets Big on Japanese Market With $3.3B Tanabe Buy
The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...
How can a pharma company survive after its golden goose stops laying?
Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...